Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 36 Roma 25 Naples 18 Bologna 12 Genova 12
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS San Raffaele160 AstraZeneca137 Merck Sharp & Dohme LLC98 Hoffmann-La Roche80 Novartis Pharmaceuticals73 Clear sponsor filter
Site location
Milan36 Roma25 Naples18 Bologna12 Genova12
All 61 locations
Target enrolment
to

Trials with a site in Milan

36 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
GlaxoSmithKline
Phase 3
800
Milan
2026-07-27
Recruiting
GlaxoSmithKline
Phase 3
450
Meldola, Rozzano MI, Bari, Bologna, Candiolo, Genova, Milan, Padova
2025-12-03
Recruiting
GlaxoSmithKline
Phase 2
363
Milan, Naples, Roma
2025-10-30
Recruiting
GlaxoSmithKline
Phase 1/2
47
Milan
2025-10-20
Recruiting
GlaxoSmithKline
Phase 3
420
Milan, Bergamo, Genova, Orbassano, Pisa, Siena, Verona
2025-08-11
Active, closed
GlaxoSmithKline
Phase 2
168
Milan, Palermo, Pavia, Siena
2025-08-06
Recruiting
GlaxoSmithKline
Phase 1/2
451
Milan, Pisa, Roma
2025-06-11
Recruiting
GlaxoSmithKline
Phase 2
80
Udine, Catania, Florence, Milan, Orbassano to, Rozzano MI
2025-06-05
Recruiting
GlaxoSmithKline
Phase 1/2
305
Milan, Roma, Naples
2025-03-04
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
DrugsMomelotinib·Reblozyl·Luspatercept
GlaxoSmithKline
Phase 2
68
Bologna, Catania, Florence, Meldola FC, Milan, Roma
2025-02-28
Recruiting
GlaxoSmithKline
Phase 2
120
Milan, Roma, Udine
2025-02-18
Active, closed
GlaxoSmithKline
Phase 2
283
Bergamo, Florence, Milan, Naples, Padova, Pisa, Roma
2024-11-11
Recruiting
GlaxoSmithKline
Phase 1
845
Milan, Naples, Roma, Verona
2024-09-30
Recruiting
GlaxoSmithKline
Phase 2
393
Bergamo, Bologna, Messina, Milan, Padova, Roma
2024-09-27
Active, closed
GlaxoSmithKline
Phase 2
153
Genova, Milan, Naples, Roma, Sassari
2024-09-17
Recruiting
GlaxoSmithKline
Phase 3
440
Ancona, Milan, Modena, Naples, Padova, Palermo, Pavia, Pisa
2024-09-11
Recruiting
GlaxoSmithKline
Phase 1
675
Aviano PN, Milan, Naples, Roma
2024-07-02
Active, closed
GlaxoSmithKline
Phase 4
303
Brescia, Ferrara, Milan, Pisa, Reggio Emilia, Rome, Rozzano
2024-06-06
Recruiting
GlaxoSmithKline
Phase 3
864
Bolzano, Bologna, Milan, Naples, Pavia, Prato, Roma, Rozzano MI
2024-03-21
Active, closed
GlaxoSmithKline
Phase 2
316
Rozzano, Bari, Bologna, Florence, Genova, Milan, Naples, Novara
2023-11-14
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Roma, Ancona, Bari, Cagliari, Catania, Ferrara, Florence, Milan
2023-09-13
Recruiting
GlaxoSmithKline
Phase 3
892
Cagliari, Genova, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2023-08-01
Active, closed
GlaxoSmithKline
Phase 2
154
Milan, Padova, Roma
2023-04-03
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
DrugGSK4532990
GlaxoSmithKline
Phase 2
284
Florence, Milan, Modena, Padova, Palermo, Roma, Rozzano MI, San Giovanni Rotondo FG
2023-01-02
Recruiting
GlaxoSmithKline
Phase 3
109
Bologna, Catania, Milan, Naples, Novara, Pavia, Roma, Treviso
2022-09-06
Active, closed
GlaxoSmithKline
Phase 3
3,038
Genoa, Milan
2022-08-10
Active, closed
GlaxoSmithKline
Phase 3
163
Bari, Brescia, Florence, Milan, Pavia, Pisa, Roma, Torrette AN
2022-07-14
Active, closed
GlaxoSmithKline
Phase 2
360
Bergamo, Milan, Modena, Naples, Palermo, Pisa
2021-12-14
Active, closed
GlaxoSmithKline
Phase 3
40
Ancona, Bologna, Brindisi, Candiolo to, Catania, Genova, Meldola FC, Milan
2021-06-28
Active, closed
GlaxoSmithKline
Phase 2/3
758
Ancona, Avellino, Florence, Milan, Monza, Naples, Orbassano to, Perugia
2020-12-08
Active, closed
GlaxoSmithKline
Phase 3
302
Bologna, Milan, Pavia, Roma
2020-10-01
Active, closed
GlaxoSmithKline
Phase 3
242
Milan, Modena, Monza, Naples, Negrar Verona, Padova, Palermo, Roma
2020-07-14
Active, closed
GlaxoSmithKline
Phase 3
494
Bergamo, Meldola FC, Milan, Siena
2020-05-07
Active, closed
GlaxoSmithKline
Phase 3
325
Bologna, Brescia, Catanzaro, Milan, Pavia, Perugia, Ravenna, Roma
2020-04-02
Recruiting
GlaxoSmithKline
Phase 1/2
184
Genova, Milan, Padova, Roma, Torino
2019-10-25
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Milan that also match the filters currently applied.

How many clinical trials are recruiting in Milan?

19 of the 36 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Milan), 36 studies
PhaseStudiesRecruitingShare
Phase 314738.9%
Phase 213536.1%
Phase 1/24411.1%
Phase 1225.6%
Phase 2/3215.6%
Phase 4102.8%

Most active sponsors

Lead sponsors with the most studies (Milan)
Lead sponsorStudiesRecruiting
GlaxoSmithKline3619
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.